Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models.
Biomedicines（2023）
Key words
molecular imaging,patient–derived xenograft,biomarkers,targeted therapy,cellular proliferation,FLT–PET,PARP,HER2 antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined